最新消息
News & Message
:::
Trastuzumab Deruxtecan or Ramucirumab plus Paclitaxel in Gastric Cancer
Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 Study
INTEGRATE IIa Phase III Study: Regorafenib for Refractory Advanced Gastric Cancer
2026/2/3
Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer
Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer
相關文章
開關
首頁
Facebook
Instagram
體系醫院
中國醫點通